IndraLab

Statements


| 1 3 1

reach
"In addition, in a patient with metastatic colon cancer, irbesartan inhibits activator protein 1 (AP-1) DNA binding and the JUN gene, resulting in a complete functional radiological resolution of the disease, showing its enormous potential in cancer treatment [78]."

sparser
"Thus, inhibition of FOS and JUN by Nadroparin and Irbesartan may have potential applications as anti-inflammatory options for RSV infection."

reach
"However, the role of irbesartan in reducing chemotherapy resistance in PDAC has not been reported.To explore the target of irbesartan, we performed RNA-sequencing and found that c-Jun, a canonical member of the AP-1 family, was significantly repressed by irbesartan in PDAC."

eidos
"Mechanistically , we found that irbesartan decreased c-Jun expression by inhibiting the Hippo / YAP1 pathway and further overcame chemotherapy resistance in PDAC ."

reach
"Further luciferase assays indicated that irbesartan notably repressed the transcriptionally activity of the c-Jun promoter in PDAC (Fig. 4G)."